Preclinical imaging developer MILabs has won an installation of its MILabs U-SPECT+/CT system at a Dutch cancer institute, the company said.
The Netherlands Cancer Institute will install the system in its Mouse Cancer Clinic, a new preclinical research center that is part of the Mouse Clinic for Cancer and Aging and is funded by the Netherlands Organisation for Scientific Research.
The system will be used for a range of research projects featuring the development and use of advanced mouse models for cancer, particularly mammary tumorigenesis, MILabs said.
